← Back to work
Works cited by this work
171 works
Work: Exploring cellular immunotherapy platforms in multiple myeloma
Natural killer cell dysfunction in hepatocellular carcinoma and NK cell-based immunotherapy
Cheng Sun, Haoyu Sun, Weihua Xiao +2
Review article20152 citationsABINK cell receptor imbalance and NK cell dysfunction in HBV infection and hepatocellular carcinoma
Cheng Sun, Haoyu Sun, Cai Zhang +1
Review article20142 citationsABIEmerging combination treatment strategies containing novel agents in newly diagnosed multiple myeloma
Review article20092 citationsABIPersonalized Dendritic Cell-Based Tumor Immunotherapy
Nona Janikashvili, Nicolas Larmonier, Emmanuel Katsanis
Review article20092 citationsABITowards efficient cancer immunotherapy: advances in developing artificial antigen-presenting cells
Loek J. Eggermont, Leonie E. Paulis, Jurjen Tel +1
Review article20142 citationsABIEnhancement of Dendritic Cells as Vaccines for Cancer
Meghan E. Turnis, Cliona M. Rooney
Review article20102 citationsABIRegulation of Dendritic Cell Migration to the Draining Lymph Node
Alfonso Martin‐Fontecha, Silvia Sebastiani, Uta E. Höpken +4
Article20032 citationsABITargeting B-Cell Maturation Antigen in Multiple Myeloma
Yu‐Tzu Tai, Kenneth C. Anderson
Review article20152 citationsABIThe immunotherapy era of myeloma: monoclonal antibodies, vaccines, and adoptive T-cell therapies
Valentina Hoyos, Ivan Borrello
Review article20162 citationsABIGlobal Manufacturing of CAR T Cell Therapy
Bruce L. Levine, James Miskin, Keith Wonnacott +1
Review article20172 citationsABIImmunotherapy for the treatment of multiple myeloma
Sung‐Hoon Jung, Hyunju Lee, Manh-Cuong Vo +2
Review article20172 citationsABIAxicabtagene Ciloleucel CAR T-Cell Therapy in Refractory Large B-Cell Lymphoma
Sattva S. Neelapu, Frederick L. Locke, Nancy L. Bartlett +37
Article20172 citationsABICellular immunotherapy in multiple myeloma
Manh-Cuong Vo, Thangaraj Jaya Lakshmi, Sung‐Hoon Jung +7
Review article20192 citationsABI